Active Ingredient(s):Bromfenac FDA Approved: * April 11, 2016 Pharm Company: *INSITE VISION INC Category:Vision / Eye Health
Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) marketed in the US as an ophthalmic solution (brand names Prolensa and Bromday, prior formulation brand name Xibrom, which has since been discontinued) by ISTA Pharmaceuticals for short-term, local use. Prolensa and Bromday are the once-daily formulation of bromfenac, while Xibrom was approved for twice-daily administration. In the European Union, the brand name is Yellox. Bromfenac is indicated f...
* May have multiple approval dates, manufacturers, or labelers.